Register Cart 0

Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back Subscribe

Editorial [Hot topic: Brave New World? Arrestin Pathway Bias in Drug Design (Guest Editor: Bradley T. Andresen)]

Author(s): Bradley T. Andresen and Louis M. Luttrell

Volume 11, Issue 2, 2011

Page: [90 - 91] Pages: 2

DOI: 10.2174/187153011795564142

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

8

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Treatment of Acute Hypercalcemia
Medicinal Chemistry

Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
Current Hypertension Reviews

Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism
Current Hypertension Reviews

Evolution of Biomarker Guided Therapy for Heart Failure: Current Concepts and Trial Evidence
Current Cardiology Reviews

The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
Current Pharmaceutical Design

Endothelial Dysfunction in Heart Failure: Mechanisms and Therapeutic Approaches
Current Vascular Pharmacology

The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors
Current Pharmaceutical Design

Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets

Mechanisms Involved in Apoptosis Events Contributing to Sepsis-Induced Myocardial Dysfunction
Current Drug Therapy

Role of Sulfonamide Group in Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry

The HAG Mechanism: A Molecular Rationale For The Therapeutic Application Of Iron Chelators In Human Diseases Involving the 2-Oxoacid Utilizing Dioxygenases
Current Medicinal Chemistry

Antiangiogenic Therapeutic Approaches in Multiple Myeloma
Current Cancer Drug Targets

Xanthine Derivatives in the Heart: Blessed or Cursed?
Current Medicinal Chemistry

Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Current Genomics

Dronedarone: A Safety Comparison to Amiodarone
Current Drug Safety

Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology

Histamine as a Potential Adjuvant to Immuno and Radiotherapy for Cancer Treatment: Discovering New Functions for the Oldest Biogenic Amine
Current Immunology Reviews (Discontinued)

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Current Cancer Drug Targets

A Historical Overview on Coronary Surgery and Interventional Cardiology: Parallel Pathways?
Vascular Disease Prevention (Discontinued)

Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
Current Vascular Pharmacology

© 2024 Bentham Science Publishers | Privacy Policy